Change over period
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max
XOMA Corp
NASDAQ XOMAP
Data sourced from
and
and
XOMA Corp Operating Cash Flow To Current Liabilities for the year ending December 31, 2023: -0.93
XOMA Corp Operating Cash Flow To Current Liabilities is -0.93 for the year ending December 31, 2023, a 50.70% change year over year. The operating cash flow to current liabilities ratio measures the ability of a company's operating cash flow to cover its current liabilities. It is calculated by dividing the operating cash flow by the current liabilities. This ratio indicates the company's short-term liquidity position and its ability to meet its immediate financial obligations using cash generated from its operations. A higher ratio suggests a stronger ability to cover current liabilities with operating cash flow.
-
XOMA Corp Operating Cash Flow To Current Liabilities for the year ending December 31, 2022 was -1.89, a -208.01% change year over year.
-
XOMA Corp Operating Cash Flow To Current Liabilities for the year ending December 31, 2021 was 1.75, a 113.19% change year over year.
-
XOMA Corp Operating Cash Flow To Current Liabilities for the year ending December 31, 2020 was 0.82, a 2,654.61% change year over year.
-
XOMA Corp Operating Cash Flow To Current Liabilities for the year ending December 31, 2019 was -0.03.
Don’t Miss A Beat
Looking to stay ahead of the competition and stay informed? Receive your daily dose of market news, trends, and analysis to kickstart your day and stay up-to-date.
NASDAQ: XOMAP
| CEO | - |
| IPO Date | Dec. 16, 2020 |
| Location | United States |
| Headquarters | 2200 Powell Street, EmeryVille, CA, United States, 94608 |
| Employees | 13 |
| Sector | Healthcare |
| Industry | Biotechnology |
Description
XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
Key trends
Similar companies
XOMA Corporation
NA
NA
StockViz Staff
September 19, 2024
Any question? Send us an email